Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Risk factors

New risk-assessment guidelines—more or less personalized?

Nature Reviews Cardiology volume 11, pages 136–137 (2014)Cite this article

Subjects

The new ACC/AHA cardiovascular-risk guidelines feature updated equations for women, distinct equations for African–American individuals, and include stroke prediction. However, the equations rely on the same traditional risk factors as previous versions, are driven predominantly by age, and curtail the intermediate-risk group, in which personalized risk assessment is recommended.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The Framingham Risk Score, and adapted versions in previous guidelines, was used to identify a large group of intermediate-risk patients for whom further testing to enhance risk stratification was recommended.

References

  1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285, 2486–2497 (2001).

  2. Wilson, P. W. et al. Prediction of coronary heart disease using risk factor categories. Circulation 97, 1837–1847 (1998).

    Article  CAS  Google Scholar 

  3. Goff, D. C. Jr et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. http://dx.doi.org/10.1016/j.jacc.2013.11.005.

  4. Pandey, A. K. et al. Family history of coronary heart disease and the incidence and progression of coronary artery calcification: Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 115, 2722–2730 (2013).

    Google Scholar 

  5. Ioannidis, J. P. More than a billion people taking statins? Potential implications of the new cardiovascular guidelines. JAMA http://dx.doi.org/10.1001/jama.2013.284657.

  6. Ridker, P. M. & Cook, N. R. Statins: new American guidelines for prevention of cardiovascular disease. Lancet 382, 1762–1765 (2013).

    Article  Google Scholar 

  7. Yeboah, J. et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA 308, 788–795 (2012).

    Article  CAS  Google Scholar 

  8. Blaha, M. J. et al. Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study. Lancet 378, 684–692 (2011).

    Article  CAS  Google Scholar 

  9. Taylor, A. J., Merz, C. N. & Udelson, J. E. 34th Bethesda Conference: executive summary—can atherosclerosis imaging techniques improve the detection of patients at risk for ischemic heart disease? J. Am. Coll. Cardiol. 41, 1860–1862 (2003).

    Article  Google Scholar 

  10. Silverman, M. G. et al. Impact of coronary artery calcium on coronary heart disease events in individuals at the extremes of traditional risk factor burden: the Multi-Ethnic Study of Atherosclerosis (MESA). Eur. Heart J. (in press).

Download references

Author information

Authors and Affiliations

  1. The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Carnegie 565A, Johns Hopkins Hospital, 600 N. Wolfe Street, Baltimore, 21287, MD, USA

    Michael J. Blaha & Roger S. Blumenthal

Authors
  1. Michael J. Blaha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roger S. Blumenthal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael J. Blaha.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blaha, M., Blumenthal, R. New risk-assessment guidelines—more or less personalized?. Nat Rev Cardiol 11, 136–137 (2014). https://doi.org/10.1038/nrcardio.2013.216

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2013.216

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing